Health Equity Starts Here.
Real Change Starts Now.
Real Change Starts Now.
Dedicated to R&D and Clinicals Trials providing evidence generation and innovation
Stage 1: Evidence, Data & Innovation
Dedicated to R&D and clinical trials providing evidence generation and innovation, this stage highlights the science behind femtech. From inclusive trial design and regulatory pathways to pharma–startup partnerships and digital biomarkers, discover how research is closing the gender data gap and accelerating women’s health breakthroughs.
Who Should Attend
- Pharma → pipeline scouting and trial innovation
- Clinical trials professionals → recruitment, endpoints, AI and digital biomarkers
- Clinicians → evidence based updates
- Insurance providers → review data and evidence to inform policy and reimbursement
Key Topics
Focus: R&D, clinical trials, regulatory science, digital biomarkers, and evidence generation
- Inclusive clinical trial design and representation of women
- AI and digital biomarkers to accelerate trials and endpoints
- Regulatory pathways across FDA, EMA, and global approvals
- Pharma and startup collaborations for novel therapies and devices
- Evidence based clinical updates shaping adoption
- Real world evidence, post market surveillance, and outcome analytics
- Innovative recruitment and retention strategies for diverse populations
